Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii

EMBO Journal

Volumn 17, Issue 23, 1998, Pages 6812-6818

  Jasanoff, Alan ^a   Wagner, Gerhard ^b   Wiley, Don C ^a  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Immunology; Invariant chain; Major histocompatibility complex class II; Nuclear magnetic resonance; Protein structure

Indexed keywords

CHAPERONIN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; CARBOXY TERMINAL SEQUENCE; ENDOPLASMIC RETICULUM; GENETIC CONSERVATION; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TARGETING;

EID: 0032401758     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.23.6812     Document Type: Article

References (24)

1. Bertolino, P. et al. (1995) Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chain's oligomer formation and class II antigen presentation. J. Immunol., 154, 5620-5629.
2. Bevec, T., Stoka, V., Pungercic, G., Dolenc, I. and Turk, V. (1996) Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J. Exp. Med. 183, 1331-1338.
3. Bijlmakers, M.J., Benaroch, P. and Ploegh, H.L. (1994) Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J. Exp. Med., 180, 623-629.
4. Brünger, A.T. (1992) X-PLOR (version 3.1) Manual. Yale University, New Haven, CT.
5. Denzin, L.K., Hammond, C. and Cresswell, P. (1996) HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med., 184, 2153-2165.
6. Freisewinkel, I.M., Schenck, K. and Koch, N. (1993) The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc. Natl Acad. Sci. USA, 90, 9703-9706.
7. Gedde-Dahl, M., Freisewinkel, I., Staschewski, M., Schenck, K., Koch, N. and Bakke, O. (1997) Exon 6 is essential for invariant chain trimerization and induction of large endosomal structures. J. Biol. Chem., 272, 8281-8287.
8. Ghosh, P., Amaya, M., Mellins, E. and Wiley, D.C. (1995) The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature, 378, 457-162.
9. Holm, L. and Sander, C. (1995) Dali: a network tool for protein structure comparison. Trends Biochem. Sci., 20, 478-480.
10. Jasanoff, A. (1998) An asymmetric deuterium labeling strategy to identify interprotomer and intraprotomer NOEs in oligomeric proteins. J. Biomol. NMR, 12, 299-306.
11. Jasanoff, A., Park, S.-J. and Wiley, D.C. (1995) Direct observation of disordered regions in the major histocompatibility complex class II-associated invariant chain. Proc. Natl Acad. Sci. USA, 92, 9900-9904.
12. Karp, D.R., Jenkins, R.N. and Long, E.O. (1992) Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins. Proc. Natl Acad. Sci. USA, 89, 9657-9661.
13. Kim, J., Urban, R.G., Strominger, J.L. and Wiley, D.C. (1994) Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science, 266, 1870-1874.
14. Koch, N., Lauer, W., Habicht, J. and Dobberstein, B. (1987) Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii): an alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin. EMBO J., 6, 1677-1683.
15. Kraulis, P. (1991) Molscript, a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr., 24, 946-950.
16. Machamer, C.E. and Cresswell, P. (1982) Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. J. Immunol., 129, 2564-2569.
17. Nicholls, A., Sharp, K. and Honig, B. (1991) Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins, 11, 281-296.
18. Nilges, M. (1993) A calculational strategy for the structure determination of symmetric dimers by 1H NMR. Proteins: Struct. Funct. Genet., 17, 297-309.
19. Park, S.-J. (1995) Studies of the Invariant Chain. Harvard, Cambridge, MA.
20. Park, S.-J., Sadegh-Nasseri S. and Wiley, D.C. (1995) Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1. Proc. Natl Acad. Sci. USA, 92, 11289-11293.
21. Roche, P.A., Marks, M.S. and Cresswell, P. (1991) Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature, 354, 392-394.
22. Romagnoli, P. and Germain, R.N. (1994) The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport and peptide occupancy. J. Exp. Med., 180, 1107-1113.
23. Walters, K.J., Matsuo, H. and Wagner, G. (1997) Use of deuteration to distinguish intermonomer NOEs in homodimeric proteins with C2 symmetry. J. Am. Chem. Soc., 119, 5958-5959.
24. Xia, T. and Bartels, C. (1994) XEASY User Manual. ETH-Hönggerberg, Zürich.